The iRGD peptide binds to αv integrins and neuropilin-1 (NRP-1), which is overexpressed in glioblastoma and other brain cancers, significantly enhancing the cellular uptake of therapeutic agents (40). This evidence concerns the gene NRP1 and glioblastoma.